186 related articles for article (PubMed ID: 30194234)
1. Radioactive (
Guryev EL; Volodina NO; Shilyagina NY; Gudkov SV; Balalaeva IV; Volovetskiy AB; Lyubeshkin AV; Sen' AV; Ermilov SA; Vodeneev VA; Petrov RV; Zvyagin AV; Alferov ZI; Deyev SM
Proc Natl Acad Sci U S A; 2018 Sep; 115(39):9690-9695. PubMed ID: 30194234
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Study of Biofunctional Polymer-Coated Upconversion Nanoparticles.
Guryev EL; Shilyagina NY; Kostyuk AB; Sencha LM; Balalaeva IV; Vodeneev VA; Kutova OM; Lyubeshkin AV; Yakubovskaya RI; Pankratov AA; Ingel FI; Novik TS; Deyev SM; Ermilov SA; Zvyagin AV
Toxicol Sci; 2019 Jul; 170(1):123-132. PubMed ID: 30985900
[TBL] [Abstract][Full Text] [Related]
3. UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer.
Guryev EL; Smyshlyaeva AS; Shilyagina NY; Sokolova EA; Shanwar S; Kostyuk AB; Lyubeshkin AV; Schulga AA; Konovalova EV; Lin Q; Roy I; Balalaeva IV; Deyev SM; Zvyagin AV
Molecules; 2020 Sep; 25(18):. PubMed ID: 32961731
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of the optical imaging of a breast cancer lesion labeled with upconversion nanoparticle biocomplexes.
Grebenik EA; Nadort A; Generalova AN; Nechaev AV; Sreenivasan VK; Khaydukov EV; Semchishen VA; Popov AP; Sokolov VI; Akhmanov AS; Zubov VP; Klinov DV; Panchenko VY; Deyev SM; Zvyagin AV
J Biomed Opt; 2013 Jul; 18(7):76004. PubMed ID: 23843082
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet phototoxicity of upconversion nanoparticles illuminated with near-infrared light.
Mironova KE; Khochenkov DA; Generalova AN; Rocheva VV; Sholina NV; Nechaev AV; Semchishen VA; Deyev SM; Zvyagin AV; Khaydukov EV
Nanoscale; 2017 Oct; 9(39):14921-14928. PubMed ID: 28952637
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.
Li DL; Tan JE; Tian Y; Huang S; Sun PH; Wang M; Han YJ; Li HS; Wu HB; Zhang XM; Xu YK; Wang QS
Biomaterials; 2017 Dec; 147():86-98. PubMed ID: 28938164
[TBL] [Abstract][Full Text] [Related]
7. Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts.
Jin J; Xu Z; Zhang Y; Gu YJ; Lam MH; Wong WT
Adv Healthc Mater; 2013 Nov; 2(11):1501-12. PubMed ID: 23630101
[TBL] [Abstract][Full Text] [Related]
8. DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells.
Proshkina G; Deyev S; Ryabova A; Tavanti F; Menziani MC; Cohen R; Katrivas L; Kotlyar A
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34645-34651. PubMed ID: 31448887
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Complexes Based on Photoluminescent Upconversion Nanoparticles for Theranostics of the HER2-Positive Tumors.
Guryev EL; Smyshlyaeva AS; Shilyagina NY; Shanwar S; Kostyuk AB; Shulga AA; Konovalova EV; Zvyagin AV; Deyev SM; Petrov RV
Dokl Biochem Biophys; 2020 Mar; 491(1):73-76. PubMed ID: 32483755
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of upconversion nanoparticles conjugated with graphene oxide quantum dots and their use against cancer cell imaging and photodynamic therapy.
Choi SY; Baek SH; Chang SJ; Song Y; Rafique R; Lee KT; Park TJ
Biosens Bioelectron; 2017 Jul; 93():267-273. PubMed ID: 27590213
[TBL] [Abstract][Full Text] [Related]
11. Amine-functionalized, porous silica-coated NaYF
Reddy KL; Sharma PK; Singh A; Kumar A; Shankar KR; Singh Y; Garg N; Krishnan V
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():86-95. PubMed ID: 30606601
[TBL] [Abstract][Full Text] [Related]
12. Polymer-coated NaYF₄:Yb³⁺, Er³⁺ upconversion nanoparticles for charge-dependent cellular imaging.
Jin J; Gu YJ; Man CW; Cheng J; Xu Z; Zhang Y; Wang H; Lee VH; Cheng SH; Wong WT
ACS Nano; 2011 Oct; 5(10):7838-47. PubMed ID: 21905691
[TBL] [Abstract][Full Text] [Related]
13. Upconversion nanoparticles in bioassays, optical imaging and therapy.
Nguyen PD; Son SJ; Min J
J Nanosci Nanotechnol; 2014 Jan; 14(1):157-74. PubMed ID: 24730257
[TBL] [Abstract][Full Text] [Related]
14. The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth.
Sokolova EA; Proshkina GM; Kutova OM; Balalaeva IV; Deyev SM
Acta Naturae; 2017; 9(3):103-107. PubMed ID: 29104782
[TBL] [Abstract][Full Text] [Related]
15. Silica coated upconversion nanoparticles: a versatile platform for the development of efficient theranostics.
Liu JN; Bu WB; Shi JL
Acc Chem Res; 2015 Jul; 48(7):1797-805. PubMed ID: 26057000
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Evaluation of Upconversion Nanoparticles Based miRNA Delivery Carrier in Colon Cancer Mice Model.
Shi H; Liang GF; Li Y; Li JH; Jing AH; Feng WP; Li GD; Du JX; Feng SY
J Biomed Nanotechnol; 2019 Nov; 15(11):2240-2250. PubMed ID: 31847938
[TBL] [Abstract][Full Text] [Related]
17. Development of injectable upconversion nanoparticle-conjugated doxorubicin theranostics electrospun nanostructure for targeted photochemotherapy in breast cancer.
Khan A; Tripathi A; Gandhi M; Bellare J; Srivastava R
J Biomed Mater Res A; 2024 Mar; ():. PubMed ID: 38545952
[TBL] [Abstract][Full Text] [Related]
18. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
Lee J; Lee TS; Ryu J; Hong S; Kang M; Im K; Kang JH; Lim SM; Park S; Song R
J Nucl Med; 2013 Jan; 54(1):96-103. PubMed ID: 23232276
[TBL] [Abstract][Full Text] [Related]
19. On The Latest Three-Stage Development of Nanomedicines based on Upconversion Nanoparticles.
Fan W; Bu W; Shi J
Adv Mater; 2016 Jun; 28(21):3987-4011. PubMed ID: 27031300
[TBL] [Abstract][Full Text] [Related]
20. Peptide-functionalized upconversion nanoparticles-based FRET sensing platform for Caspase-9 activity detection in vitro and in vivo.
Liu L; Zhang H; Wang Z; Song D
Biosens Bioelectron; 2019 Sep; 141():111403. PubMed ID: 31176111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
